BSECompany Update22 Jun 2026
Gland Pharma Ltd
Schedule of Investor Meet
Gland Pharma Ltd has intimated the stock exchanges about a scheduled analyst/institutional investor meeting. The company will be conducting a one-on-one meeting with Ambit PMS on June 25, 2026. This intimation is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule remains subject to change due to exigencies from the investor, analyst, or the company.
Read more →📎 1 attachment